Related Experiment Video
Updated: Sep 11, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Developing, Analyzing, and Interpreting Outcome Assessments to Improve Endpoints in Infectious Diseases Clinical
John H Powers1,2,3, Robert J O'Connell4
1Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Abstract:
Evidence from clinical research studies, in addition to patient values and clinical experience, helps practitioners best apply medical interventions to clinical practice. Part of evaluating the evidence is understanding the outcomes used as endpoints in research studies. The most direct evidence of patient benefit comes from endpoints that evaluate the effects of interventions on patient survival, symptoms, and function, and the impact of symptoms and function on health-related quality of life. In this article, we discuss how to develop endpoints for clinical research studies focusing on patient-reported outcome measures, including those measuring patient symptoms, function, and health-related quality of life. We discuss the process for determining (1) which concepts to measure, including which concepts are most relevant to patients (content validity); (2) who performs the measurement and which measurement properties to use (construct validity); and (3) how to analyze and interpret the results obtained using the chosen measurements.
Related Concept Videos
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Preclinical Development: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Steps in Outbreak Investigation
Introduction to Epidemiology

